These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12372606)

  • 1. Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.
    Gourdier I; Del Rio M; Crabbé L; Candeil L; Copois V; Ychou M; Auffray C; Martineau P; Mechti N; Pommier Y; Pau B
    FEBS Lett; 2002 Oct; 529(2-3):232-6. PubMed ID: 12372606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA.
    Gourdier I; Crabbe L; Andreau K; Pau B; Kroemer G
    Oncogene; 2004 Sep; 23(45):7449-57. PubMed ID: 15334062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
    Sordet O; Rébé C; Leroy I; Bruey JM; Garrido C; Miguet C; Lizard G; Plenchette S; Corcos L; Solary E
    Blood; 2001 Jun; 97(12):3931-40. PubMed ID: 11389037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines.
    Nakagawa Y; Akao Y; Morikawa H; Hirata I; Katsu K; Naoe T; Ohishi N; Yagi K
    Life Sci; 2002 Mar; 70(19):2253-69. PubMed ID: 12005185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of apoptosis mechanism of arsenic trioxide on oral squamous cell carcinoma].
    Guo J; Zhang ZY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):20-3. PubMed ID: 12760770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
    J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.
    Griffiths GJ; Koh MY; Brunton VG; Cawthorne C; Reeves NA; Greaves M; Tilby MJ; Pearson DG; Ottley CJ; Workman P; Frame MC; Dive C
    J Biol Chem; 2004 Oct; 279(44):46113-21. PubMed ID: 15326164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.
    Zhang XL; Hu AB; Cui SZ; Wei HB
    World J Gastroenterol; 2012 Feb; 18(7):646-53. PubMed ID: 22363135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway.
    Wang DH; Wei HL; Zhao HS; Hao CY; Min ZH; Liu JM
    Pharmacol Res; 2005 Nov; 52(5):376-85. PubMed ID: 15979894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.
    Arango D; Wilson AJ; Shi Q; Corner GA; Arañes MJ; Nicholas C; Lesser M; Mariadason JM; Augenlicht LH
    Br J Cancer; 2004 Nov; 91(11):1931-46. PubMed ID: 15545975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arsenic trioxide induced apoptosis in retinoblastoma cells in vitro and its possible mechanism].
    Li Y; Tang LS; Shen HW
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):476-80. PubMed ID: 18599993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.
    Toscano F; Parmentier B; Fajoui ZE; Estornes Y; Chayvialle JA; Saurin JC; Abello J
    Biochem Pharmacol; 2007 Aug; 74(3):392-406. PubMed ID: 17559811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
    Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.